The allegations are adding up against the former Actavis unit in the UK A couple of months after competition watchdogs took issue with a 12,000% price hike on hydrocortisone tablets, authorities are rolling out new claims the company entered “anticompetitive” and “illegal” agreements on the med.
The UK’s Competition and Markets Authority on Friday said agreements by Actavis and Concordia delayed competition for the drug, used by thousands of patients in the UK as a primary replacement therapy for adrenal insufficiency.
Israel’s Teva bought Actavis for $40.5 billion last summer and subsequently offloaded the UK outfit as mandated by antitrust authorities. In an email today, Teva said that while it received the CMA complaint, Actavis UK “has never in practice been controlled by Teva due to the hold separate obligation to the European Commission.”
Accord Healthcare, a subsidiary of India’s Intas, recently picked up the generics portfolio in a deal worth about $767 million.
Full Content: Law 360
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI